Biotechnology is most attractive area for investors in China


Biotechnology is most attractive area for investors in China

According to 2017 study conducted by China National Pharmaceutical Industry Information Center, biotechnology companies increased profits by 12% last year.

The executive director of Chanson & Co notes that biotechnology companies are very attractive for investors. According to him, the Chinese have started taken care of their health more thoroughly and are interested in health products today.

There are officially 105 billionaires in China working in the field of pharmaceutical biotechnology.


Subscribe to the news of M-Health Congress on Facebook and VK!

Innovation news

Selection of health gadgets from CES 2019: part 2

Previous week, M-Health Congress told you about the first top six most impressive health devices...

Global healthcare 2019: development of digital technologies and personalized medicine

Analysts from Deloitte forecast that the global healthcare expenditures may rise to $10.1 trillion by...

Digital medicine as a way to reduce healthcare paperwork

According to Frost&Sullivan, the market of digital healthcare solutions will reach $6 billion by 2021...